PCN355 DO PAYER AND PRESCRIBER ENDPOINT PREFERENCES ALIGN?: IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.550
https://www.valueinhealthjournal.com/article/S1098-3015(19)32928-6/fulltext
Section Title :
Section Order :
10470
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32928-6&doi=10.1016/j.jval.2019.09.550